No photo of Charles Lopez

View Scopus Profile

Charles Lopez

Associate Professor

  • 1001 Citations
  • 17 h-Index
1990 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Charles Lopez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways

Lopez, C.

National Institutes of Health

9/1/04 → 6/30/10

Project: Research project

    • P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2

    Lopez, C.

    National Institutes of Health

    6/7/00 → 5/31/05

    Project: Research project

    • Research Output

    • 1001 Citations
    • 17 h-Index
    • 29 Article
    • 5 Review article
    • 2 Comment/debate

    Effect of Time to Surgery of Colorectal Liver Metastases on Survival

    Chen, E. Y., Mayo, S. C., Sutton, T., Kearney, M. R., Kardosh, A., Vaccaro, G. M., Billingsley, K. G. & Lopez, C. D., Jan 1 2020, (Accepted/In press) In : Journal of Gastrointestinal Cancer.

    Research output: Contribution to journal › Article

    Open Access

    • Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma

    Allen-Petersen, B. L., Risom, T., Feng, Z., Wang, Z., Jenny, Z. P., Thoma, M. C., Pelz, K. R., Morton, J. P., Sansom, O. J., Lopez, C. D., Sheppard, B., Christensen, D. J., Ohlmeyer, M., Narla, G. & Sears, R. C., Jan 1 2019, In : Cancer Research. 79, 1, p. 209-219 11 p.

    Research output: Contribution to journal › Article

    • 16 Scopus citations

    Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia

    Schittenhelm, M. M., Walter, B., Tsintari, V., Federmann, B., Bajrami Saipi, M., Akmut, F., Illing, B., Mau-Holzmann, U., Fend, F., Lopez, C. & Kampa-Schittenhelm, K. M., Apr 1 2019, In : EBioMedicine. 42, p. 340-351 12 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    A phase II study alternating erlotinib with second-line mFOLFOX6 or FOLFIRI for metastatic colorectal cancer

    Kearney, M. R., Chen, E. Y., Vaccaro, G. M., Strother, J., Burt, A., Todd, K., Donovan, J., Kampa-Schittenhelm, K. M. & Lopez, C. D., Jan 2019, In : Anticancer research. 39, 1, p. 245-252 8 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Evolving Treatment Options and Future Directions for Locally Advanced Rectal Cancer

    Chen, E. Y., Kardosh, A., Nabavizadeh, N. & Lopez, C. D., Dec 2019, In : Clinical Colorectal Cancer. 18, 4, p. 231-237 7 p.

    Research output: Contribution to journal › Review article

    • 1 Scopus citations